Triptorelin (Trelstar)

FDA-approved product existsPeptideGH axis & hormones

Awaiting review, BioHarmony verdict

Not yet scored. Queued for review; until then rely on the status and sources below.

What is Triptorelin (Trelstar)?

FDA-approved triptorelin is marketed as Trelstar depot formulations for palliative treatment of advanced prostate cancer, with product-specific dosing intervals.

Saved on this device only.

Dosing as published

Source-reported figures only. This page does not calculate a personal dose.

Approved labelTRELSTAR prescribing information for advanced prostate cancer
PopulationAdults covered by the approved TRELSTAR indication
Dose3.75 mg every 4 weeks, 11.25 mg every 12 weeks, or 22.5 mg every 24 weeks; strengths are not additive or interchangeable by simple summation.
RouteSingle intramuscular injection in either buttock
FrequencyEvery 4, 12, or 24 weeks according to the selected formulation
DurationLong-term use within the approved indication
PreparationLyophilized microsphere suspension supplied with its formulation-specific diluent and MIXJECT transfer system; reconstitute only as directed for the selected 3.75 mg, 11.25 mg, or 22.5 mg product and administer immediately.
Source: Dosage and Administration sections 2.1-2.2; Instructions for Reconstitution

Working with a vial? The reconstitution calculator covers mixing math, not dosing advice.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

  1. Last revieweddone
  2. Next reviewupcoming
US approvalFDA-approved product exists
CompoundingFDA-approved product exists; compounded copies are not FDA approved

Primary sources

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.